REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 78 filers reported holding REVOLUTION MEDICINES INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $19,343,282 | +24.1% | 698,818 | +19.9% | 0.00% | +100.0% |
Q2 2023 | $15,587,547 | -39.9% | 582,712 | -51.3% | 0.00% | 0.0% |
Q1 2023 | $25,934,428 | +153.3% | 1,197,342 | +178.6% | 0.00% | 0.0% |
Q4 2022 | $10,237,050 | +20.0% | 429,767 | -0.7% | 0.00% | 0.0% |
Q3 2022 | $8,534,000 | +567.8% | 432,750 | +560.2% | 0.00% | – |
Q2 2022 | $1,278,000 | -98.3% | 65,553 | -97.7% | 0.00% | -100.0% |
Q1 2022 | $73,138,000 | -52.4% | 2,867,020 | -53.0% | 0.01% | -45.5% |
Q4 2021 | $153,580,000 | -28.4% | 6,101,724 | -21.8% | 0.01% | -35.3% |
Q3 2021 | $214,521,000 | -29.1% | 7,797,884 | -18.2% | 0.02% | -29.2% |
Q2 2021 | $302,618,000 | -39.1% | 9,534,259 | -12.0% | 0.02% | -42.9% |
Q1 2021 | $496,984,000 | +34.4% | 10,832,245 | +16.0% | 0.04% | +27.3% |
Q4 2020 | $369,750,000 | +7.4% | 9,339,485 | -5.6% | 0.03% | -5.7% |
Q3 2020 | $344,135,000 | +38.8% | 9,888,961 | +25.1% | 0.04% | +29.6% |
Q2 2020 | $247,946,000 | +72.4% | 7,903,725 | +18.6% | 0.03% | +35.0% |
Q1 2020 | $143,824,000 | – | 6,664,063 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Nextech Invest Ltd. | 4,839,529 | $104,824,198 | 43.76% |
Column Group LLC | 4,577,840 | $99,156,014 | 35.85% |
Mass General Brigham, Inc | 338,191 | $7,325 | 5.71% |
Boxer Capital, LLC | 4,684,264 | $101,461 | 4.98% |
BVF INC/IL | 4,955,588 | $107,338,036 | 3.92% |
DAFNA Capital Management LLC | 575,785 | $12,471,503 | 3.74% |
EcoR1 Capital, LLC | 5,352,183 | $115,928,284 | 3.73% |
Casdin Capital, LLC | 1,810,000 | $39,204,600 | 3.23% |
Artal Group S.A. | 2,070,988 | $44,858 | 2.66% |
Integral Health Asset Management, LLC | 345,000 | $7,472,700 | 1.50% |